Hot Stock List: China Distance Education Holdings Limited (NYSE:DL), Anika Therapeutics Inc. (NASDAQ:ANIK), Esperion Therapeutics (NASDAQ:ESPR), Cisco Systems (NASDAQ:CSCO), j2 Global (NASDAQ:JCOM)

China Distance Education Holdings Limited (NYSE:DL) belongs to Services sector. Its net profit margin is 23.50% and weekly performance is -12.88%. On last trading day company shares ended up $14.07. China Distance Education Holdings Limited (NYSE:DL) distance from 50-day simple moving average (SMA50) is -20.19%. On July 06, China Distance Education Holdings Limited (NYSE:DL) announced its participation in the following investor conferences in August 2015: Credit Suisse North Asia Internet C-Level Conference, August 26-27, in Hong Kong at Credit Suisse’s office in the International Commerce Centre, and August 28 in Singapore at the Ritz-Carlton Millenia Hotel.

Anika Therapeutics Inc. (NASDAQ:ANIK) shares moved up 0.94% in last trading session and ended the day at $33.33. ANIK Gross Margin is 76.00% and its return on assets is 14.20%. Anika Therapeutics Inc. (NASDAQ:ANIK) quarterly performance is -18.11%. Anika Therapeutics Inc. (NASDAQ:ANIK) reported positive results from the CINGAL® 13-02 study evaluating the safety of a repeat injection of CINGAL for symptomatic relief of osteoarthritis (OA) of the knee. CINGAL combines the Company’s proprietary cross-linked sodium hyaluronate (currently marketed as the single-injection viscosupplement MONOVISC®) with an FDA-approved steroid, triamcinolone hexacetonide. Earlier this year, Anika announced positive results from CINGAL 13-01, a randomized, double-blind, placebo-controlled Phase 3 study, which demonstrated the efficacy and safety of a single injection of CINGAL for treatment of pain caused by OA of the knee.

On 10 July, Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares moved up 1.49% and was closed at $90.01. ESPR EPS growth in last 5 year was -17.80%. Esperion Therapeutics, Inc. (NASDAQ:ESPR) year to date (YTD) performance is 122.58%. On July 07, Esperion Therapeutics, Inc. (NASDAQ:ESPR) announced that the U.S. Food and Drug Administration (FDA) has removed the 240 mg partial clinical hold on ETC-1002 (bempedoic acid). This action by FDA will now allow ETC-1002 to be used at doses above 240 mg in clinical studies. Esperion plans to initiate the Phase 3 clinical program for ETC-1002 in the fourth quarter of this year using the already optimized 180 mg dose.

Cisco Systems, Inc. (NASDAQ:CSCO) belongs to Technology sector. Its net profit margin is 18.30% and weekly performance is -0.18%. On last trading day company shares ended up $27.28. Cisco Systems, Inc. (NASDAQ:CSCO) distance from 50-day simple moving average (SMA50) is -4.35%. On July 07, Cisco Systems, Inc. (NASDAQ:CSCO) announced a deal to buy privately held MaintenanceNet for $139 million, the latest acquisition for the network giant.

j2 Global, Inc. (NASDAQ:JCOM) shares moved up 1.35% in last trading session and ended the day at $66.83. JCOM Gross Margin is 82.30% and its return on assets is 8.60%. j2 Global, Inc. (NASDAQ:JCOM) quarterly performance is -1.63%. On July 07, KeepItSafe and j2 Global, Inc. (NASDAQ:JCOM) announced the launch of KeepItSafe Cloud2Cloud, to back up files stored in the cloud. With Cloud2Cloud, users can back up data held in cloud-based SaaS applications such as Microsoft Office 365, Salesforce.com and Google Apps, as well as platforms like Windows Azure and Amazon Web Services.

Leave a Reply

Your email address will not be published. Required fields are marked *